Paul Voigt - Oct 29, 2024 Form 4 Insider Report for INNOVATE Corp. (VATE)

Signature
/s/ Paul Voigt
Stock symbol
VATE
Transactions as of
Oct 29, 2024
Transactions value $
$0
Form type
4
Date filed
10/30/2024, 04:39 PM
Previous filing
Sep 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VATE Common Stock Award $0 +95.3K +45.04% $0.00 307K Oct 29, 2024 Direct F1
transaction VATE Common Stock Award $0 +143K +46.54% $0.00 450K Oct 29, 2024 Direct F2
holding VATE Common Stock 7.54K Oct 29, 2024 Jessie Holdings LLC F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VATE Stock option (Right To Buy) Award $0 +100K $0.00 100K Oct 29, 2024 Common Stock 100K $25.00 Direct F4, F5, F6
transaction VATE Stock option (Right To Buy) Award $0 +100K $0.00 100K Oct 29, 2024 Common Stock 100K $4.22 Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock unit award (the "RSU") was granted on October 11, 2023, subject to stockholder approval of an amendment to the Second Amended and Restated 2014 Omnibus Equity Award Plan (the "Second A&R 2014 Plan") to increase the number of shares of Common Stock available thereunder to satisfy the settlement of the grant (the "Share Approval Condition"), which was approved by the stockholders on October 4, 2024 effective as of October 29, 2024.
F2 The RSU was granted on August 19, 2024, subject to the Share Approval Condition, which was approved by the stockholders on October 4, 2024 effective as of October 29, 2024.
F3 Reporting Person is the Manager of Jessie Holdings LLC and has sole voting and investment control.
F4 The option award was granted with an exercise price of $25.00 per share (retroactively adjusted to reflect the 1-for-10 reverse split of the Common Stock effective as of August 8, 2024), which price was greater than the fair market value per share on the date of the grant.
F5 The option award was granted on September 15, 2023, subject to the Share Approval Condition, which was approved by the stockholders on October 4, 2024 effective as of October 29, 2024.
F6 The reported shares have been retroactively adjusted to reflect the 1-for-10 reverse split of the Issuer's Common Stock effective as of August 8, 2024.
F7 The option award was granted on September 15, 2024 with an exercise price to be set at 110% of the 10-day VWAP on the date of the grant.
F8 The option award was granted on September 15, 2024, subject to the Share Approval Condition, which was approved by the stockholders on October 4, 2024 effective as of October 29, 2024.